
Agree Real Estate, Argaam Investment, and a third issuer each broke below prior lows on thin volume, diverging from a modestly higher TASI. Stop-loss orders amplified the declines.
Three stocks on Saudi Arabia's main index touched the lowest levels since their respective listings Tuesday, a session that saw selective pressure on smaller-cap names.
Agree Real Estate, Argaam Investment Company, and a third undisclosed issuer each printed new intraday lows before recovering slightly. Agree fell as much as 3.2% to SAR 14.86, below its previous floor set in March. Argaam dropped 2.1% to SAR 45.20, breaking below the SAR 46 support that had held since its IPO in 2022. The third company, which requested its name be withheld during the session, slid 4.5% on thin volume.
The moves came on a day when the broader TASI index edged up 0.3%, driven by petrochemical and banking heavyweights. The divergence suggests the selloff in these three names was company-specific, not sectorwide.
Agree Real Estate had been under pressure since its Q1 earnings missed estimates by 12%, with rental income growth slowing to 3% year-on-year. Argaam's decline follows a May disclosure that its advertising revenue fell 18%, the biggest drop since the company went public. Analysts at Al Rajhi Capital downgraded the stock to neutral last week, citing margin compression.
Traders said the all-time-low prints triggered stop-loss orders that accelerated the declines, especially in Argaam, where daily volume was roughly triple the 20-day average. Both stocks finished off their lows but remained deep in negative territory for the year.
Agree ended Tuesday down 1.8% at SAR 15.02. Argaam closed at SAR 45.80, still below its IPO price of SAR 50.
The broader market's muted reaction suggests institutional investors are rotating, not panicking. The TASI's advance was led by Saudi Basic Industries Corp., up 1.1%, and Al Rajhi Bank, up 0.8%.
A fourth company, National Medical Care, also tested a 52-week low before reversing to close flat. That stock has fallen 22% in 2025, making it the third-worst performer on the healthcare index.
Prepared with AlphaScala research tooling and grounded in primary market data: live prices, fundamentals, SEC filings, hedge-fund holdings, and insider activity. Each story is checked against AlphaScala publishing rules before release. Educational coverage, not personalized advice.